Qutenza 179mg cutaneous patches United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

qutenza 179mg cutaneous patches

grunenthal ltd - capsaicin - cutaneous patch - 179mg

Bettamousse 0.1% cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bettamousse 0.1% cutaneous foam

necessity supplies ltd - betamethasone valerate - cutaneous foam - 1mg/1gram

Bettamousse 0.1% cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bettamousse 0.1% cutaneous foam

de pharmaceuticals - betamethasone valerate - cutaneous foam - 1mg/1gram

Actikerall 5mg/g / 100mg/g cutaneous solution United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actikerall 5mg/g / 100mg/g cutaneous solution

almirall ltd - fluorouracil; salicylic acid - cutaneous solution - 5mg/1gram ; 100mg/1gram

Soleve Sunburn Relief cutaneous emulsion United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

soleve sunburn relief cutaneous emulsion

diomed developments ltd - cutaneous emulsion

Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

enstilar 50micrograms/g / 0.5 mg/g cutaneous foam

leo pharma - betamethasone dipropionate; calcipotriol monohydrate - cutaneous foam - 500microgram/1gram ; 50microgram/1gram

Hipraject Subcutaneous Philippines - English - FDA (Food And Drug Administration)

hipraject subcutaneous

hipra philippines, inc.; distributor: hipra philippines, inc. - subcutaneous vaccination device (vet.) - subcutaneous - not applicable

Neoclarityn European Union - English - EMA (European Medicines Agency)

neoclarityn

n.v. organon - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistamines for systemic use, - neoclarityn is indicated for the relief of symptoms associated with:allergic rhinitisurticaria

Tavneos European Union - English - EMA (European Medicines Agency)

tavneos

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunosuppressants - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

Aluspray 4% w/w Cutaneous Spray, Powder Ireland - English - HPRA (Health Products Regulatory Authority)

aluspray 4% w/w cutaneous spray, powder

vetoquinol ireland limited - aluminium - cutaneous spray, powder - 4 percent weight/weight - aluminium agents - cats, cattle, dogs, horses, other birds, pigs, sheep - antibacterial